Stay updated on JCAR014 and Durvalumab in Lymphoma Clinical Trial
Sign up to get notified when there's something new on the JCAR014 and Durvalumab in Lymphoma Clinical Trial page.

Latest updates to the JCAR014 and Durvalumab in Lymphoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision updated from v3.5.2 to v3.5.3, indicating a minor update to the page's revision history. The change does not modify visible content or user-facing features.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision updated: v3.5.2 was added and v3.5.0 was removed.SummaryDifference0.0%

- Check51 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0, indicating a minor metadata update with no changes to study details or results.SummaryDifference0.0%

- Check58 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check87 days agoChange DetectedSite revision v3.4.2 was added and the government funding status notice from v3.4.1 was removed; no study content changes were made. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check94 days agoChange DetectedA government funding lapse notice banner was added and the site was updated to revision 3.4.1, replacing 3.4.0.SummaryDifference0.2%

Stay in the know with updates to JCAR014 and Durvalumab in Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JCAR014 and Durvalumab in Lymphoma Clinical Trial page.